Event Information

[QUEBEC EDITION] Precision Medicine in Prostate Cancer: Multidisciplinary Perspectives in Identifying, Managing and Optimizing Patient Care

Type
Speaker’s Tour

EVENT DETAILS

Display Date
Wednesday November 17, 2021 /// 19:00-20:30 ET • 20:00-21:30 AT
Location
Virtual
Speaker
Fred Saad, Zineb Hamilou, Evan Weber

ACCREDITATION

Accreditation
1.5 Section 1 Group Learning Credits
Event Description

This session will be presented in French, with simultaneous interpretation available in English.

Cette session sera présentée en Français, avec une interprétation simultanée en anglais.  

image

 Learning Objectives: 

  • Describe the significance and appropriate timing for testing for germline and somatic mutations in mCRPC
  • Evaluate the different modalities and avenues for testing
  • Review clinical safety and efficacy data for PARP inhibitors
  • Discuss the rationale for PARP inhibitor utilization in HRR-mutated mCRPC 
REGISTER
Footer

 Sponsor:

logo logo

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy